Karma Bio Health is dedicated to creating 

advanced performance pharmaceutical formulations.

Using our proprietary excipients, Zenergy™ and Rhesolv™, we formulate drugs for higher bioavailability, faster onset, and easier administration. Drugs previously available only via injections can now be given in nasal, inhalation and oral formats, resulting in better performance with higher patient compliance and satisfaction.

In addition, Karma Bio utilizes cutting-edge digital dispensing technology that can make our formulations easier and safer for use, allowing log-and-lock capabilities to reduce issues around diversion, overdosing and abuse, while simultaneously allowing greater insight into patient use characteristics and enabling seamless EHR integration to facilitate better care where appropriate.

Team

Glen Cunningham,

MBA, BSN,BSc,RN

Chief Executive Officer 

Charles Bentz,

MD, FACP

Chief Medical Officer

Sammi Molvi, 

RPh, B. Pharm, B.S. Business

Chief Scientific Officer

Kirk Gerner,

Chair

Sinhow Chin,

CFO

For more information, please Contact Us